Cashing in on dementia patients: drugmaker to pay $116 million in fraud settlement

A pharmaceutical company that whistleblowers alleged paid doctors to prescribe its main drug and urged salespeople to push it as a way to control unruly dementia patients will pay more than $100 million to settle government fraud allegations.

from CNN.com - RSS Channel - App International Edition https://www.cnn.com/2019/09/26/health/nuedexta-avanir-doj-settlement-invs/index.html
via IFTTT